News Release
September 26, 2013
Merck Millipore Accepts Stevie Awards for Direct Detect® and Muse® Products at the
2013 American Business AwardsSM
- Two Merck Millipore products received awards at the 11th Annual Stevie® Awards on September 16 in San Francisco
September 26, 2013, Darmstadt, Germany — Merck Millipore, the Life Science division of Merck, accepted a Silver Stevie® Award for their Muse® Cell Analyzer and a Bronze Stevie® Award for their Direct Detect® Protein Quantitation System. These awards were distributed by the American Business AwardsSM, the premier business award program in the United States. Finalists were announced in June, with the recipient announced at the New Product and Technology Awards Banquet on Monday, September 16 in San Francisco. Finalists and rankings were decided upon by a panel of over 200 business executives nationwide. The awards are given as a national recognition to new products that have impacted their industries in significant ways.
Accepting these awards for Merck Millipore was Warren Hinds, Operations Manager for Merck Millipore. “I was honored to attend the ceremony and accept the awards on behalf of the Merck Millipore R&D, Applications and Operations teams,” said Warren. “We are proud of our accomplishment, and the recognition by the ABA. The awards acknowledge the long history of innovation that has been a hallmark of our success at Merck Millipore.”
The Muse® Cell Analyzer is a miniaturized benchtop flow cytometer that provides greater accuracy and precision than manual hemocytometry or image-based automated analysis, delivering multi-dimensional information on cell populations. More compact, affordable, and simpler to use than traditional systems, the Muse® Cell Analyzer is accessible to researchers of all levels, empowering faster, more accurate decision-making; for more productive workflows and better insight into cell health, apoptosis, cell signaling, immune response and other commonly studied cell mechanisms.
The Direct Detect® system for rapid, simplified protein quantitation taps into Merck Millipore’s membrane expertise to enable infrared-based measurement of amide bonds in protein chains, an intrinsic component of every protein, without relying on amino acid composition, dye-binding properties or redox potential. The Direct Detect® system enables researchers to improve the speed and accuracy of their quantitation, a necessary component of most downstream applications.
More than 3,000 nominations from organizations of all sizes and virtually every industry were submitted to The American Business AwardsSM for consideration in a wide range of categories, including Most Innovative Company of the Year, Management Team of the Year, Best New Product or Service of the Year, and Executive of the Year. Roughly 35% of submissions were named finalists by a panel of more than 200 executives over five weeks of judging. Merck Millipore’s Muse® and Direct Detect® products received awards in the New Product of the Year category for Health and Pharmaceutical Products.
Details about The American Business Awards and the list of finalists in all categories are available at www.stevieawards.com/aba.
For more information on Muse® and Direct Detect® products visit www.merckmillipore.com/directdetect and www.merckmillipore.com/muse.
About Merck Millipore
Merck Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2012 revenues of € 2.6 billion. Merck Millipore operates as EMD Millipore in the U.S. and Canada.
Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a global pharmaceutical, chemical and life science company with total revenues of € 11.2 billion in 2012, a history that began in 1668, and a future shaped by approx. 39,000 employees in 66 countries. Its success is characterized by innovations from entrepreneurial employees. Merck KGaA's operating activities come under the umbrella of Merck KGaA, Darmstadt, Germany, in which the Merck family holds an approximately 70% interest and shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Worldwide there are two separate companies that bear the name “Merck”, the original Merck KGaA from Darmstadt, Germany, the oldest pharmaceutical and chemical company in the world, and the pharmaceutical company Merck & Co. in the United States. The rights to the name and trademark MERCK in North America (USA and Canada) lie with Merck & Co., the former U.S. subsidiary of Merck, whereas Merck KGaA operates in North America under the umbrella brand EMD. In the rest of the world, Merck KGaA owns the rights to the Merck name and trademark.
About the Stevie® Awards
Stevie® Awards are conferred in four programs: The American Business AwardsSM, The International Business Awards, the Stevie® Awards for Women in Business, and the Stevie® Awards for Sales & Customer Service. Honoring organizations of all types and sizes and the people behind them, the Stevie® Awards recognize outstanding performances in the workplace worldwide. Learn more about The Stevie® Awards at www.stevieawards.com.